Bob Nelsen (Michael Kovac/Getty Images)

Scoop: Bob Nelsen is build­ing a Re­al­ly Big Neu­ro­science Com­pa­ny

Over the last year, ARCH man­ag­ing di­rec­tor Bob Nelsen has been qui­et­ly rais­ing hun­dreds of mil­lions of dol­lars to launch a mas­sive neu­ro­science-fo­cused biotech.

The com­pa­ny has been fil­ing doc­u­ments out of ARCH’s San Fran­cis­co of­fice since at least May of 2020. Fit­ting­ly for Nelsen — the ven­ture cap­i­tal­ist who ini­tial­ly chris­tened the CAR-T com­pa­ny Juno “Fuck Can­cer” and the cell ther­a­py be­he­moth Sana “Fuck Dis­ease” — the biotech is op­er­at­ing un­der a co­de­name: RB­NC Ther­a­peu­tics. It stands, a source said, for Re­al­ly Big Neu­ro­science Com­pa­ny.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.